From Wikipedia, the free encyclopedia - View original article
|Dutch Elm Disease|
|Causal agents:||Ophiostoma ulmi|
|vectors:||elm bark beetle|
|Distribution:||Europe and New Zealand|
|Dutch Elm Disease|
|Causal agents:||Ophiostoma ulmi|
|vectors:||elm bark beetle|
|Distribution:||Europe and New Zealand|
Dutch elm disease (DED) is caused by a member of the sac fungi (Ascomycota) affecting elm trees, and is spread by the elm bark beetle. Although believed to be originally native to Asia, the disease has been accidentally introduced into America New Zeland and Europe, where it has devastated native populations of elms which had not had the opportunity to evolve resistance to the disease. The name "Dutch elm disease" refers to its identification in 1921 and later in the Netherlands by Dutch phytopathologists Bea Schwarz and Christine Buisman who both worked with Professor Johanna Westerdijk. The disease is not specific to the Dutch elm hybrid.
The origin of O. novo-ulmi remains unknown; it was widely believed to have originated in China, but a comprehensive survey there in 1986 found no trace of it, although elm bark beetles were very common.
DED is spread in North America by three species of bark beetles (Family: Curculionidae, Subfamily: Scolytinae):
In Europe, while S. multistriatus again acts as vector for infection, it is much less effective than the large elm bark beetle, S. scolytus. H. rufipes can be a vector for the disease, but is inefficient compared to the other vectors. S. schevyrewi was found in 2003 in Colorado and Utah.
In an attempt to block the fungus from spreading farther, the tree reacts by plugging its own xylem tissue with gum and tyloses, bladder-like extensions of the xylem cell wall. As the xylem (one of the two types of vascular tissue produced by the vascular cambium, the other being the phloem) delivers water and nutrients to the rest of the plant, these plugs prevent them from travelling up the trunk of the tree, eventually killing it. (Xylem comprises the bulk of the hard tissue of the interior of trunks and branches of woody plants and is nearly synonymous with "wood". Phloem can be thought of as a thin sheet of tissue wrapped around the central cylinder of xylem, although just beneath the phloem is another thin sheet, the vascular cambium, which produces both phloem and xylem.)
The first symptom of infection is usually an upper branch of the tree with leaves starting to wither and yellow in summer, months before the normal autumnal leaf shedding. This progressively spreads to the rest of the tree, with further dieback of branches. Eventually, the roots die, starved of nutrients from the leaves. Often, not all the roots die: the roots of some species, notably the English elm Ulmus procera, put up suckers which flourish for approximately 15 years, after which they too succumb.
Dutch elm disease was first noticed in Europe in 1910, and spread slowly, reaching Britain in 1927 and eventually extending to all other countries in Europe except Greece and Finland. This first strain was a relatively mild one, which killed only a small proportion of elms, more often just killing a few branches, and had largely died out by 1940 owing to its susceptibility to viruses. The disease was isolated in The Netherlands in 1921 by Bea Schwarz, a pioneering Dutch phytopathologist, and this discovery would lend the disease its name.
Circa 1967, a new, far more virulent strain arrived in Britain on a shipment of Rock Elm U. thomasii logs from North America, and this strain proved both highly contagious and lethal to European elms; more than 25 million trees have died in the UK alone, while France has lost over 90% of her elms. The disease is still migrating northwards through Scotland, reaching Edinburgh in the late 1970s, and Inverness in 2006. By 1990, very few mature elms were left in Britain or much of continental Europe. One of the most distinctive English countryside trees (See John Constable's painting Salisbury Cathedral from the South-West), the English elm U. procera Salisb., is particularly susceptible. Thirty years after the outbreak of the epidemic, nearly all these trees, which often grew to more than 45 m high, are gone. The species still survives in hedgerows, as the roots are not killed and send up root sprouts ("suckers"). These suckers rarely reach more than 5 m tall before succumbing to a new attack of the fungus. However, established hedges kept low by clipping have remained apparently healthy throughout the nearly 40 years since the onset of the disease in the UK.
The largest concentrations of mature elms in Europe are now in Amsterdam and The Hague. In 2005, Amsterdam was declared the 'Elm City of Europe': the city’s streets and canals are lined with at least 75,000 elms, including several generations of research-elms (see below: Resistant trees). Some 30,000 of the 100,000 mature trees in The Hague are elms, planted because of their tolerance of salty sea-winds. Since the 1990s, a programme of antifungal injections of the most prominent 10,000 elms, and of sanitation felling, has reduced annual elm losses in The Hague from 7% to less than 1% (see below: Preventive treatment). The losses are made up by the planting of disease-resistant cultivars. The largest concentration of mature elm trees remaining in England is in Brighton and Hove, East Sussex, where of the 30,000 elms in 1983 15,000 still stand (2005 figures), several of which are estimated to be over 400 years old. Their survival is owing to the isolation of the area, between the English Channel and the South Downs, and the assiduous efforts of local authorities to identify and remove infected sections of trees immediately when they show symptoms of the disease. Empowered by the Dutch Elm Disease (Local Authorities) (Amendment) Order 1988, local authorities may order the destruction of any infected trees or timber, although in practice they usually do it themselves, successfully reducing the numbers of elm bark beetle Scolytus spp., the vector of elm disease. Sanitary felling has also, to date, preserved most of the 250,000 elms on the Isle of Man.
The largest concentration of mature elms in Scotland is in Edinburgh, where over 5000 mature elms still stand (2009 figures) out of some 35,000 in 1976. Edinburgh's Leith Links has the highest concentration of mature elms of any U.K. park (2012). A policy of sanitary felling has kept losses in the city to an average of 1000 a year. Elm was the commonest tree in Paris from the 17th century; before the 1970s there were some 30,000 ormes parisiens. Today, only 1000 mature elms survive in the city, including examples in the large avenues (Avenue d'Italie, Avenue de Choisy, Boulevard Lefebvre, Boulevard de Grenelle, Boulevard Garibaldi) and two very old specimens, one in the garden of the Tuileries in front of the l'Orangerie and another in the Place Saint-Gervais in front of l'hôtel de ville de Paris. Losses are now being made up with disease-resistant cultivars, especially the Dutch-French research elm 'Nanguen' (Lutèce), named after the city.
The disease was first reported in the United States in 1928, with the beetles believed to have arrived in a shipment of logs from The Netherlands destined for use as veneer in the Ohio furniture industry. The disease spread slowly from New England westward and southward, almost completely destroying the famous elms in the 'Elm City' of New Haven, reaching the Detroit area in 1950, the Chicago area by 1960, and Minneapolis by 1970. Of the estimated 77 million elms in North America in 1930, over 75% had been lost by 1989.
Dutch elm disease reached eastern Canada during the Second World War, and spread to Ontario in 1967, Manitoba in 1975 and Saskatchewan in 1981. In Toronto, 80% of the elm trees have been lost to Dutch elm disease; many more fell victim in Ottawa, Montreal and other cities during the 1970s and 1980s. Quebec City still has about 21,000 elms, thanks to a prevention program initiated in 1981. Alberta and British Columbia are the only provinces that are currently free of Dutch elm disease, although, in an isolated case, an elm tree in southeastern Alberta found diseased in 1998 was immediately destroyed. Today, Alberta has the largest number of elms unaffected by Dutch elm disease in the world; many streets and parks in Edmonton and Calgary are still lined with healthy, mature trees. Aggressive measures are being taken to prevent the spread of the disease into Alberta, as well as other parts of Canada. The City of Edmonton has banned elm pruning from March 31 to October 1, since fresh pruning wounds will attract the beetles during the warmer months.
The largest surviving urban forest of elm trees in North America is believed to be in the city of Winnipeg, Manitoba, where close to 200,000 elms remain – at least double that of Amsterdam, the "Elm City of Europe". The city of Winnipeg spends $3 million annually to aggressively combat the disease using Dursban Turf and the Dutch Trig vaccine, losing 1500–4000 trees per year.
Dutch elm disease has reached New Zealand. It was found in Napier where it was eradicated and was also found in the Auckland Region in 1989. The Ministry of Agriculture funded a national management programme but it was cancelled to allow more funds to be available for pests of a higher priority. A major outbreak occurred in New Zealand in July 2013, particularly at the site of Kingseat Hospital.
The first attempts to control Dutch elm disease consisted of pruning trees to remove and burn diseased timber. While this method was effective in New York State and adjacent areas, its cost made it uneconomical except in large cities where elms were considered valuable attractions.
When Dutch elm disease spread away from the Atlantic coast, control focused on controlling the bark beetle by means of such insecticides as DDT and dieldrin, which were sprayed heavily across all parts of elm trees, usually twice a year in the spring and again at a lower concentration in the summer. In its early years it was generally thought by observers that pesticides did slow the spread of the disease across the United States but as early as 1947 concern was raised that many bird species were killed in large numbers via ingesting poisoned invertebrates. In areas sprayed during the 1950s local people observed birds such as the American Woodcock, American Robin, White-breasted Nuthatch, Brown Creeper and various Poecile species dying. Biologist Rachel Carson consequently argued against spraying elms and for improved sanitation, which she saw as having been more effective in areas with earlier and greater experience countering Dutch elm disease. Although modern critics of Carson have argued that the bird deaths were caused by other factors such as mercury poisoning in the soil, spraying against elm bark beetles declined very rapidly after 1962, a trend aided by fungicides without dangerous side-effects being discovered for the first time after many years of research.
Lignasan BLP (carbendazim phosphate), introduced in the 1970s, was the first fungicide used to control Dutch elm disease. This had to be injected into the base of the tree using specialized equipment, and was never especially effective. It is still sold under the name "Elm Fungicide". Arbotect (thiabendazole hypophosphite) became available some years later, and it has been proven effective. Arbotect must be injected every two to three years to provide ongoing control; the disease generally cannot be eradicated once a tree is infected. There is a process called tracing that was invented by Rainbow Treecare in Minneapolis. It has proven to be effective at saving infected elms as long as the Dutch elm disease fungus has not grown into the roots.
Arbotect is not effective on root graft infections from adjacent elm trees. It is more than 99.5% effective for three years from beetle infections, which is the primary mode of tree infection.
Alamo (propiconazole) has become available more recently, though several university studies show it to be effective for only the current season it is injected. Alamo is primarily recommended for treatment of oak wilt.
Because of the ban on the use of chemicals on street and park trees in the Netherlands, the University of Amsterdam developed a biological vaccine by the late 1980s. Dutch Trig is nonchemical and nontoxic, consisting of a suspension in distilled water of spores of a strain of the fungus Verticillium albo-atrum that has lost much of its pathogenic capabilities, injected in the elm in spring. The strain is believed to have enough pathogenicity left to induce an immune response in the elm, protecting it against DED during one growing season. This is called induced resistance. Trials with the American elm have been very successful; in a six-year experiment with the American elm in Denver, CO, annual Dutch elm disease losses declined significantly after the first year from seven to between 0.4 and 0.6 per cent; a greater and more rapid reduction in disease incidence than the accompanying tree sanitation and plant health care programs.
Preventive treatment is usually only justified when a tree has unusual symbolic value or occupies a particularly important place in the landscape.
Research to select resistant cultivars and varieties began in the Netherlands in 1928, followed by the USA in 1937. Initial efforts in the Netherlands involved crossing varieties of U. minor and U. glabra, but later included the Himalayan or Kashmir elm U. wallichiana as a source of antifungal genes. Early efforts in the USA involved the hybridization of the Siberian elm U. pumila with American red elm U. rubra to produce resistant trees. Resulting cultivars lacked the traditional shape and landscape value of the American elm; few were planted.
In 2005, the National Elm Trial (USA) began a 10-year evaluation of 19 cultivars in plantings across the United States. The trees in the trial are exclusively American developments; no European cultivars have been included.
Elms are tested for resistance by inoculation with the fungal pathogen in late May when the tree's growth is at its annual peak. Clones raised for testing are grown to an age of 3 or 4 years. In Europe, the inoculum is introduced into the cambium by a knife wound. However this method, developed in the Netherlands, was considered too severe in America, where the principal disease vector is the bark beetle Scolytus multistriatus, a far less effective vector than the larger beetle endemic to Europe, Scolytus scolytus, which is unknown in America. In the method devised by the USDA, the inoculum is introduced to the cambium via a 2 mm-diameter hole drilled through the bark in the lower third of the tree. This method was further refined by the University of Wisconsin team, which drilled holes in the branches to simulate natural infection by the bark beetles feeding in the twig crotches, but results from this method were found to exaggerate the genetic resistance of the host. Consequently, tests were conducted on specimens in a controlled environment, either in greenhouses or customized plant chambers, facilitating more accurate evaluation of both internal and external symptoms of disease.
Another variable is the composition of the inoculum; while an inoculum strength of 106 spores / ml is standard in both continents, its composition reflects the different Ophiostoma species, subspecies and hybrids endemic to the two continents. In Italy for example, two subspecies, americana and novo-ulmi, are present together with their hybrid, whereas in North America, ssp. novo-ulmi is unknown.  The differences in method and inocula possibly explain why the American cultivar 'Princeton', displaying high resistance in the USA, has often succumbed to Dutch elm disease in Europe. 
Many attempts to breed disease resistant cultivar hybrids have usually involved a genetic contribution from Asian elm species which have demonstrable resistance to this fungal disease. Much of the early work was undertaken in the Netherlands. The Dutch research programme began in 1928, and ended after 64 years in 1992, during which time well over 1000 cultivars were raised and evaluated. The programme had three major successes: 'Columella', 'Nanguen' LUTÈCE, and 'Wanoux' VADA, all found to have an extremely high resistance to the disease when inoculated with unnaturally large doses of the fungus. Only 'Columella' was released during the lifetime of the Dutch programme, in 1987; patents for the LUTÈCE and VADA clones were purchased by the French Institut National de la Recherche Agronomique (INRA), which subjected the trees to 20 years of field trials in the Bois de Vincennes, Paris, before releasing them to commerce in 2002 and 2006, respectively.
Asian species to feature in the American DED research programs were the Siberian elm U. pumila, Japanese elm U. davidiana var. japonica, and the Chinese elm U. parvifolia, giving rise to several dozen hybrid cultivars resistant not just to DED, but also to the extreme cold of Asian winters. Among the most widely planted of these, both in North America and in Europe, are 'Sapporo Autumn Gold' and 'New Horizon'. Some hybrid cultivars, such as 'Regal', are the product of both Dutch and American research. Hybridization experiments using the slippery or red elm U. rubra resulted in the release of 'Coolshade' and 'Rosehill' in the 1940s and 50s. The species last featured in hybridization as the female parent of 'Repura' and 'Revera', both patented in 1993, although neither has yet appeared in commerce.
In Italy, research is continuing at the Istituto per la Protezione delle Piante, Florence, to produce a range of disease-resistant trees adapted to the warmer Mediterranean climate, using a variety of Asiatic species crossed with the early Dutch hybrid 'Plantyn' as a safeguard against any future mutation of the disease. Two trees with very high levels of resistance, 'San Zanobi' and 'Plinio', were released in 2003. 'Arno' and 'Fiorente' were patented in 2006 and entered commerce in 2012. All four have the Siberian elm U. pumila as a parent, the source of disease-resistance and drought-tolerance genes. Further releases are planned, notably of the clone 'Morpheo', derived from a crossing of Dutch elm Ulmus × hollandica with the Chinese species U. chenmoui, currently available commercially only in England (Ashridge Trees Limited).
Ten resistant American elm U. americana cultivars are now in commerce in North America, but only two ('Princeton' and 'Valley Forge') are currently available in Europe. No cultivar is "immune" to DED; even highly resistant cultivars can become infected, particularly if already stressed by drought or other environmental conditions where the disease prevalence is high. With the exception of 'Princeton', no trees have yet been grown to maturity. Trees cannot be said to be mature until they have reached an age of 60 years.
Notable cultivars include:
In 2007, the Elm Recovery Project from the University of Guelph in Ontario, Canada reported that cuttings from healthy surviving old elms surveyed across Ontario had been grown to produce a bank of resistant trees, isolated for selective breeding of highly resistant cultivars  .
The University of Minnesota USA is testing various elms, including a huge now-patented century-old survivor known as "The St. Croix Elm", which is located in a Minneapolis-St. Paul, MN suburb (Afton) in the St. Croix River valley — a designated National Scenic Riverway.
The slippery or red elm U. rubra is marginally less susceptible to Dutch elm disease than the other American species, but this quality seems to have been largely ignored in American research. No cultivars were ever selected, although the tree was used in hybridization experiments (see above).
Among European species, there is the unique example of the European white elm U. laevis, which has little innate resistance to DED, but is eschewed by the vector bark beetles and only rarely becomes infected. Recent research has indicated it is the presence of certain organic compounds, such as triterpenes and sterols, which serves to make the tree bark unattractive to the beetle species that spread the disease.
In Europe the testing of clones of surviving Field Elms for innate resistance has been carried out since the 1990s by national research institutes, with findings centrally assessed and published. The first results of this ongoing project suggest that in some countries a very small number of native Field Elm genotypes have comparatively high levels of tolerance to DED. In Spain, for example, of around 5,000 native elms evaluated to 2013, some 25 genotypes (0.5% of those tested) fall into this category; and it is now hoped that the controlled crossing of the best seven of these (genetically and aesthetically) will produce Ulmus minor hybrids with effective 'field resistance' and market appeal. Similar results are beginning to emerge in trials on surviving Field Elms in Greece.
Much of the work in the United Kingdom is by the Forestry Commission's research arm, which has had Dutch elm disease on its agenda since the 1920s. In 1994 a Research Information Note (no 252) was published, written by John Gibbs, Clive Brasier and Joan Webber who are still active in the field; and in 2010 a Pathology Advisory Note, as well as throughout the period a stream of more academic papers: notable results have been the observation that the progress of the disease through Scotland has been quite slow, and that genetic engineering has been tried to improve the resistance of the English elm.
In England The Conservation Foundation has begun propagating, distributing and planting clones of surviving indigenous elms, including Field Elms (but not the highly susceptible English elm), as part of a scheme to return elms to city and countryside. The Foundation is currently running two elm programmes: the 'Great British Elm Experiment' and 'Ulmus londinium', an elm programme for London – these use saplings cultivated through micropropagation from mature parent elms found growing in the British countryside: parent trees are monitored for disease, while saplings are offered free to schools and community groups, who are asked to monitor their trees' progress on the Foundation's online elm map; elms are available at a small price to others who do not qualify for a free tree; in London, places with 'elm' in their name are offered a sapling – in an attempt to find out why some elms have survived while others succumbed to Dutch elm disease. The spread of DED to Scotland has focused attention on a small number of Wych elms U. glabra surviving in areas of high infectivity, prompting the Royal Botanic Garden Edinburgh to begin a programme of cloning of the trees and inoculation of their saplings with the fungus, with a view to determining innate resistance (2010).
Independent of these programmes, clones from two UK elms, thought to be nearly 200 years old, that have so far survived in an area of high infectivity (Essex) are now available commercially. Mr Paul King of King & Co The Tree Nursery took and potted cuttings from these trees in 1990, cultivated the cuttings by micropropagation. However it should be noted that these trees have not been scientifically tested for resistance to DED. King points to the research findings of R. H. Richens in his paper "Essex Elms", which describes natural hybridisation of Ulmus species in the area and the resulting resistance to DED of some trees. Mr King does not claim that his trees are immune from DED, but the continuing survival of the original mature trees, of the first cuttings and of the micropropogated stock bodes well.
In 2001-4, English elm U. procera was genetically engineered to resist disease, in experiments at Abertay University, Dundee, Scotland, by transferring antifungal genes into the elm genome using minute DNA-coated ball bearings. However, owing to the hostility to GM developments, there are no plans to release the trees into the countryside.
From analysis of fossil pollen in peat samples, it is apparent that elms, an abundant tree in prehistoric times, all but disappeared from northwestern Europe during the mid-Holocene period about 6000 years ago, and to a lesser extent 3000 years ago. This roughly synchronous and widespread event has come to be known as the 'Elm Decline'. When first detected in the mid-20th century, the decline was attributed to the impact of forest-clearance by Neolithic farmers, and of elm-coppicing for animal fodder, though the numbers of settlers could not have been large. The devastation caused recently by DED has provided an alternative explanation. Examination of subfossil elm wood showing signs of the changes associated with the disease has suggested that a form of DED may have been responsible. Fossil finds from this period of elm bark beetles support this theory. A consensus of opinion today is that the Elm Decline was probably driven by both factors.
A less devastating form of the disease, caused by a different fungus, had possibly been present in Britain for some time. Dr Oliver Rackham of Cambridge University presented evidence of an outbreak of elm disease in north-west Europe, c.1819-1867. "Indications from annual rings [a reference to the dark staining in an annual ring in infected elms] confirm that Dutch elm disease was certainly present in 1867," he wrote, quoting contemporary accounts of diseased and dying elms, including this passage in Richard Jefferies' 1883 book, Nature near London:
Earlier still, Rackham noted, "The name Scolytus destructor was given to the great bark beetle on evidence, dating from c.1780, that it was destroying elms around Oxford."  It has been suggested, indeed, that "for thousands of years elms have flourished in natural balance with the scolytidae, combating occasional infections of Dutch elm disease."